Speratum

Speratum is rated 3 out of 5 in the category biotechnology. Read and write reviews about Speratum. Speratum is a cancer therapeutics company exploring a new frontier in the fight against cancer which targets the pathways that give rise to cancer using microRNA-based oncology therapy. Our lead candidate is a microRNA therapeutic against pancreatic cancer, offering hope for a potential treatment to this devastating disease. MicroRNA therapy is a bright future for cancer treatments. MicroRNAs are small molecules of RNA (ribonucleic acid) that are naturally occurring in the human body. Their job is to regulate and fine-tune the expression of genes, and in this way they are involved in regulating almost all aspects of human biology, including cancer. A single microRNA can regulate hundreds of genes. When this microRNA becomes dysregulated, various members of a multifactorial pathway lose their controlling element, and cancer-promoting pathways are activated. At Speratum, our mission is to synthetically replace lost microRNAs through our patented therapies and restore their original control over these cancer networks which reverses cancer aggressiveness.